![Celestine Schnugg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Celestine Schnugg
Fondateur chez
Boom Capital Management LLC
Profil
Celestine Schnugg is the founder of Boom Capital Management LLC, which was founded in 2017.
They held the title of General Partner at the firm.
Ms. Schnugg is currently an Investor at Mammoth Biosciences, Inc., Swarm Technologies, Inc. (California), Fauna Bio, Inc., A-Alpha Bio, Inc., Astra Space, Inc. (United States), and Monod Bio, Inc. Ms. Schnugg has previously worked as a Social Responsibility Associate at Apple, Inc. from 2008 to 2010 and as an Innovation Partner at Innovation Endeavors LLC from 2011 to 2015.
Postes actifs de Celestine Schnugg
| Sociétés | Poste | Début |
|---|---|---|
Boom Capital Management LLC
 Boom Capital Management LLC Investment ManagersFinance Boom Capital Ventures invests in companies located in the United States. The firm focuses on healthcare, genomics, machine intelligence, aerospace and new chemistries sectors. It participates in early-stage capital requirements. | Fondateur | 01/04/2017 |
Mammoth Biosciences, Inc.
 Mammoth Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops CRISPR-based genetic medicines, diagnostics, genome-editing technologies for healthcare and life science applications | Private Equity Investor | 10/01/2017 |
Swarm Technologies, Inc. (California)
 Swarm Technologies, Inc. (California) Specialty TelecommunicationsCommunications Provides satellite connectivity services and develops two way communication satellites | Private Equity Investor | 01/01/2018 |
Astra Space, Inc. (United States)
 Astra Space, Inc. (United States) Aerospace & DefenseElectronic Technology Manufactures satellite engines and space equipment | Private Equity Investor | 01/01/2016 |
A-Alpha Bio, Inc.
 A-Alpha Bio, Inc. Packaged SoftwareTechnology Services Develops a synthetic biology platform to aid in the development of drugs | Private Equity Investor | 01/05/2019 |
Monod Bio, Inc.
 Monod Bio, Inc. BiotechnologyHealth Technology Develops biosensors for protein and other analyte detection | Private Equity Investor | 01/07/2022 |
Fauna Bio, Inc.
 Fauna Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics | Private Equity Investor | 01/12/2018 |
Anciens postes connus de Celestine Schnugg
| Sociétés | Poste | Fin |
|---|---|---|
Innovation Endeavors LLC
 Innovation Endeavors LLC Investment ManagersFinance Innovation Endeavors invests in companies located in the United States and Israel. The firm focuses across a broad range of sectors and industries. It provides financing for seed and early stage capital requirements with an investment size of USD 1 - 15 million. It also leads or co-leads investments and also controls board seat requirements. | Corporate Officer/Principal | 01/08/2015 |
| APPLE INC. | Corporate Officer/Principal | 01/02/2010 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
73
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Apple, Inc.
 Apple, Inc. Telecommunications EquipmentElectronic Technology Designs, manufactures smartphones, personal computers, tablets, wearables and accessories | Electronic Technology |
Innovation Endeavors LLC
Innovation Endeavors LLC Investment ManagersFinance Innovation Endeavors invests in companies located in the United States and Israel. The firm focuses across a broad range of sectors and industries. It provides financing for seed and early stage capital requirements with an investment size of USD 1 - 15 million. It also leads or co-leads investments and also controls board seat requirements. | Finance |
Boom Capital Management LLC
Boom Capital Management LLC Investment ManagersFinance Boom Capital Ventures invests in companies located in the United States. The firm focuses on healthcare, genomics, machine intelligence, aerospace and new chemistries sectors. It participates in early-stage capital requirements. | Finance |
Mammoth Biosciences, Inc.
Mammoth Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops CRISPR-based genetic medicines, diagnostics, genome-editing technologies for healthcare and life science applications | Commercial Services |
Swarm Technologies, Inc. (California)
Swarm Technologies, Inc. (California) Specialty TelecommunicationsCommunications Provides satellite connectivity services and develops two way communication satellites | Communications |
Fauna Bio, Inc.
Fauna Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics | Health Technology |
A-Alpha Bio, Inc.
A-Alpha Bio, Inc. Packaged SoftwareTechnology Services Develops a synthetic biology platform to aid in the development of drugs | Technology Services |
Astra Space, Inc. (United States)
Astra Space, Inc. (United States) Aerospace & DefenseElectronic Technology Manufactures satellite engines and space equipment | Electronic Technology |
Monod Bio, Inc.
Monod Bio, Inc. BiotechnologyHealth Technology Develops biosensors for protein and other analyte detection | Health Technology |
